The U.S. Food and Drug Administration announced it is urging food manufacturers to start reducing or eliminating the use of ...

The recent update to ISO 15223-1, formalized through Amendment 1:2025, ushers in a critical shift for medical device labeling ...

The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) announced a groundbreaking decision on April 22, 2025. The agencies plan to phase out all ...

Kennedy Jr., preceded by FDA Commissioner Marty Makary, discussed his plan to phase out 8 commonly used food dyes from ...

U.S. health officials on Tuesday said they would urge food makers to phase out petroleum-based artificial colors in the ...

On April 10, 2025, the Food and Drug Administration (FDA) released a pre-recorded webinar outlining the updated "healthy" nutrient content claim ...

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

The original PROOF-HD trial of pridopidine was negative, but a new analysis showed it has clinically meaningful effects in ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies ...

Bristol Myers Squibb BMY announced that it has obtained FDA approval for the label expansion of Opdivo (nivolumab) plus Yervoy (ipilimumab). The regulatory body approved Opdivo plus Yervoy as a ...

Michael Moye, President and General Manager of Idorsia US, commented: "The fact that the FDA has expedited the approval of the updated TRYVIO label to remove the REMS requirements is, I believe ...

Michael Moye, President and General Manager of Idorsia US, commented: “The fact that the FDA has expedited the approval of the updated TRYVIO label to remove the REMS requirements is, I believe, a ...